BioScience Health Innovations, Inc. BHIC
OTC · OOTC · stock · Services-Computer Processing & Data Preparation
BioScience Health Innovations, Inc. statistics & valuation
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Gross margin | 57.0% | 70.9% | 81.1% | 86.0% | — | — | — |
| Operating margin | 12.6% | 4.7% | -42.1% | -245.8% | — | — | — |
| Net margin | 11.3% | 4.7% | -42.1% | -245.8% | — | — | — |
| Return on assets | 37.6% | 10.0% | -269.3% | -539.3% | -512.0% | -405.6% | -37.2% |
| Return on equity | 43.5% | 10.4% | 3720.4% | 992.0% | -578.1% | 200.2% | -59.9% |
Source: SEC EDGAR filings · CIK 0001784440 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.